Fakhouri, Fadi <br/><br/>
Pathogenic Variants in Complement Genes and Risk of Atypical Hemolytic Uremic Syndrome Relapse after Eculizumab Discontinuation.  [electronic resource] 

 -  Clinical journal of the American Society of Nephrology : CJASN  01 2017 
 - 50-59 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1555-905X 
<br/><br/><label>Standard No.: </label>10.2215/CJN.06440616  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Antibodies, Monoclonal, Humanized--therapeutic use<br/>Atypical Hemolytic Uremic Syndrome--drug therapy<br/>Child<br/>Child, Preschool<br/>Complement Factor H--genetics<br/>Complement System Proteins--genetics<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Male<br/>Membrane Cofactor Protein--genetics<br/>Middle Aged<br/>Recurrence<br/>Withholding Treatment<br/>Young Adult